Groundbreaking new drug shows promise for treating children with a devastating form of epilepsy
livescience - An experimental treatment reduces seizures and other symptoms in children with a type of epilepsy called Dravet syndrome.
AI Summary: An experimental treatment markedly cut seizures and eased symptoms in children with Dravet syndrome, offering families dramatic improvements where few options existed. Early clinical data show promising safety and efficacy signals, but researchers caution larger, longer trials and regulatory review are needed before this becomes a routine option.
Adding Hormone Therapy to PORT Might Not Benefit Patients with Recurrent Prostate Cancer and PSA of 0.5 ng/mL or Less
esmo - Findings from the POSEIDON meta-analysis of the MARCAP consortium
AI Summary: A pooled POSEIDON meta-analysis from the MARCAP consortium found that adding androgen-deprivation therapy to post‑operative radiotherapy for recurrent prostate cancer with PSA ≤0.5 ng/mL does not improve outcomes meaningfully. In short: the extra hormonal punch may not be worth the side effects many patients will endure.
RFK Jr. names 2 new members to CDC vaccine panel
Erica Cerutti / beckershospitalreview - HHS Secretary Robert F. Kennedy Jr. appointed two new members to the CDC’s vaccine advisory committee Feb. 27, ahead of a rescheduled meeting in mid-March where members are expected to review COVID-19 vaccine recommendations. Mr. Kennedy said Sean Downing…
AI Summary: HHS Secretary Robert F. Kennedy Jr. appointed two clinicians to the CDC’s Advisory Committee on Immunization Practices just weeks before a rescheduled session, installing new voting members ahead of vaccine deliberations. The last‑minute nominations aim to ensure the panel is fully staffed for upcoming guidance discussions.
Parents of gravely ill child refused respite care
bbc - Birmingham Children's Trust refused respite help and suggested training grandparents to help.
AI Summary: Parents of a gravely ill child report being refused respite care, leaving caregivers exhausted and without relief while bureaucratic responses pivot to training relatives. The situation exposes gaps in social and health services for high‑need families and the human cost of systems designed for checkboxes, not real lives.
After 4-Week Strike, Kaiser Permanente Workers Score Tentative Win on Staffing & Pay
Katie Adams / medcitynews - About 31,000 Kaiser Permanente workers ended a four-week strike after reaching a tentative agreement that includes measures to address chronic understaffing and wage increases. The full contract has not yet been ratified.The post After 4-Week Strike, Kais…
AI Summary: After a four‑week strike, roughly 31,000 Kaiser Permanente workers reached a tentative agreement that includes commitments on staffing levels and compensation. The deal ends a major labor standoff that had disrupted services and put pressure on management to address long‑standing workforce concerns.
CMS freezes $260M in Medicaid funding to Minnesota, citing fraud concerns
Jakob Emerson / beckershospitalreview - CMS is freezing $259.5 million in federal Medicaid funding to Minnesota, citing unsupported or potentially fraudulent claims in the state’s program. “We have decided to temporarily halt certain amounts of Medicaid funding that are going to the state of Mi…
AI Summary: Officials confirmed avian influenza in elephant seal pups at Año Nuevo State Park, prompting the suspension of seal‑watching tours and an urgent wildlife response. Several pups have died; researchers are testing samples and authorities are warning the public to avoid contact while investigations continue.
Microplastics discovered in prostate tumors
medicalxpress - Small fragments of plastic were found in 9 out of 10 patients with prostate cancer, and in higher levels inside tumors than in nearby noncancerous tissue, a new study finds. The small, single-center study was led by researchers at NYU Langone Health, its …
AI Summary: Researchers report finding microplastic fragments in the vast majority of examined prostate tumor samples, at higher levels than surrounding noncancerous tissue. The study raises uneasy questions about environmental contaminants accumulating in human tissues and their potential interactions with cancer biology, though causation remains unproven and further research is clearly overdue.
Boehringer wins accelerated approval for first-line use of lung cancer drug
Lei Lei Wu / endpoints - The FDA greenlit an expanded label for Boehringer Ingelheim’s lung cancer drug Hernexeos, marking the first use of the Commissioner's National Priority Voucher for a new indication. Boehringer won an accelerated
AI Summary: Regulators accelerated approval of Boehringer Ingelheim’s lung cancer therapy for first‑line use, leveraging a priority review mechanism that sped the timeline. The label expansion places the drug into earlier treatment settings, reflecting promising data and the efficiency (and occasional controversy) of voucher‑assisted regulatory pathways.
Patient dies in MacroGenics' cancer study, FDA puts trial on hold
Max Gelman / endpoints - The FDA has placed a partial clinical hold on MacroGenics’ Phase 2 study in gynecologic cancers after one patient died and three others experienced life-threatening side effects, the company disclosed Tuesday. The patient who died ...
AI Summary: Regulators have imposed a partial hold on a Phase 2 gynecologic cancer trial after multiple serious adverse events, including one patient death and additional safety incidents. The pause mandates review of trial protocols and safety monitoring before enrollment can resume, highlighting the inherent risks when experimental therapies meet human biology.
UHS posts 11.5% operating margin in 2025 as net income jumps 30%
Andrew Cass / beckershospitalreview - King of Prussia, Pa.-based Universal Health Services recorded a net income of $1.5 billion in 2025, up from $1.1 billion in 2024, according to its Feb. 25 financial report. Eight things to know: 1. The for-profit system reported an operating income of $2 …
AI Summary: Universal Health Services reported robust 2025 financial results and outlined an optimistic 2026 outlook, driven by acute and behavioral health operations. Leadership flagged growth targets for admissions and behavioral services even as staffing and regulatory pressures persist — the usual blend of confidence and contingency planning.
Cancer blood test fails to catch disease earlier in major study
medicalxpress - A blood test designed to find cancer early did not work as hoped in a major new study, according to the company that makes it.
AI Summary: A large trial evaluating GRAIL’s multi‑cancer blood screening test failed to meet its primary goal of earlier cancer detection. The disappointing result casts doubt on the test’s clinical utility for population screening, sparks debate over marketing and clinical use, and prompts calls for clearer evidence before widespread adoption.
More Research, Less Cancer: £250m raised to transform the future of cancer research
Charlotte Mathé / cancerresearchuk - We’ve reached an incredible moment - £250m raised for our More Research, Less Cancer campaign. This milestone brings us more than halfway to our £400m goal and accelerates our mission to prevent, detect and treat cancer earlier and more effectively. The p…
AI Summary: The More Research Less Cancer campaign has reached a £250 million fundraising milestone to accelerate cancer research, support translational projects, and expand patient-focused initiatives. Donor momentum will underwrite discovery science and clinical translation, giving researchers more runway to turn promising lab findings into treatments patients might actually see.
FDA Launches Framework to Accelerate Individualized Therapies for Ultra-Rare Diseases 2026
oncodaily - The U.S. Food and Drug Administration (FDA) has released groundbreaking draft guidance introducing a new regulatory framework designed to accelerate the development and approval of individualized therapies for patients with […]
AI Summary: The FDA released draft guidance creating a regulatory pathway to speed individualized and N-of-1 cell and gene therapies for ultra‑rare diseases. The framework clarifies evidence expectations, manufacturing and safety-monitoring options, and trial design flexibility to help get bespoke treatments from bench to bedside faster — no miracles promised, just fewer bureaucratic speed bumps.
ChatGPT Health performance in a structured test of triage recommendations
Ashwin Ramaswamy / nature - Nature Medicine, Published online: 23 February 2026; doi:10.1038/s41591-026-04297-7A stress test of ChatGPT Health triage revealed missed high-risk emergencies and inconsistent activation of suicide-crisis safeguards, raising safety concerns for consumer-…
AI Summary: A structured, independent evaluation found that ChatGPT Health—an AI tool offering consumer triage and health guidance—missed or misclassified high-risk cases and gave inconsistent advice. Researchers and clinicians raised safety concerns about relying on the system for urgent medical decision-making, calling for tighter oversight and validation before broad public deployment.
Brain injury is almost ten times more common in unhoused people. Addressing it is key to reducing homelessness
medicalxpress - On any given night, 60,000 people in Canada will go to sleep homeless. Research estimates that more than half of them have had a brain injury at one point in their lives, most of them being injured before becoming homeless. An estimated 22.5% live with mo…
AI Summary: Research indicates people experiencing homelessness suffer brain injuries at dramatically higher rates—approaching a tenfold increase—compared with housed populations. Advocates and clinicians call for routine screening, accessible neurorehabilitation, trauma-informed services and coordinated housing support to address long-term disability and reduce homelessness cycles. The findings argue treating injuries, not just symptoms, yields better social and health outcomes.
‘You’re not the Lone Ranger’ anymore: Medical education evolves for team-based care
Paige Twenter / beckershospitalreview - As U.S. healthcare increasingly adopts team-based care, medical schools are working to prepare students for future care delivery models, according to a Feb. 18 article from the Association of American Medical Colleges. Team-based care, or a coordinated ba…
AI Summary: A multi‑agent AI system called DeepRare has proven it can outpace physicians in head‑to‑head rare‑disease diagnosis tests, promising to shorten the notorious “diagnostic odyssey.” Industry leaders tout this as a practical diagnostic aid, while experts caution about validation, integration into clinical workflows and equity in access before it replaces any human judgment.
A novel C. diff vaccine shows promise
Mariah Taylor / beckershospitalreview - Nashville, Tenn.-based Vanderbilt Health researchers have developed a promising novel vaccine to treat Clostridioides difficile infections. Previous vaccine strategies targeted the bacterium’s primary toxins, according to a Feb. 18 system news release. Th…
AI Summary: Researchers at Vanderbilt have reported a novel experimental vaccine that prevents Clostridioides difficile infection and reduces recurrence in early studies, demonstrating strong protective immune responses. The work offers a much‑needed alternative to antibiotics and recurrent‑infection management, though larger clinical trials will be required to confirm safety, durability and real‑world impact.
Predicting onset of symptomatic Alzheimerʼs disease with plasma p-tau217 clocks
Kellen K. Petersen / nature - Nature Medicine, Published online: 19 February 2026; doi:10.1038/s41591-026-04206-yPlasma p-tau217 tests used to develop clocks that predict when cognitively unimpaired individuals would develop symptoms of Alzheimerʼs disease.
AI Summary: A Nature Medicine study presents plasma p‑tau217 “clocks” that estimate when symptomatic Alzheimer’s disease is likely to begin, offering a blood-based forecast years before cognitive decline appears. The test could reshape trial enrollment, early intervention timing and patient counseling—validation and access hurdles remain, but at least worried boomers get a calendar to dread.
CDC confirms 910 measles cases in 2026; South Carolina remains hardest hit
Paige Twenter / beckershospitalreview - Six weeks into 2026, the CDC has confirmed 910 measles cases. If the pace of transmission continues, this year could far outpace the 2,280 cases detected across the U.S. in 2025, as 2026’s total is already 40% of 2025’s. The hardest-hit state is South Car…
AI Summary: The CDC has confirmed a nationwide uptick in measles cases, tallying hundreds of infections and triggering local public-health responses. Hotspots include a large South Carolina outbreak, an over‑40‑case cluster at a Florida college and a Los Angeles County case involving visits to LAX eateries while infectious. Officials urge vaccination and vigilance.
Mysterious Virus Hiding Inside Common Gut Bacterium Linked to Colorectal Cancer
discovermagazine - A previously unknown virus may be the key to assessing the risk of colorectal cancer and improving diagnosis.
AI Summary: Scientists have identified a novel virus residing within a common gut bacterium that appears associated with colorectal cancer, offering a potential new biomarker for risk and diagnosis. Early work suggests this viral–microbe interaction could reshape screening strategies if subsequent studies confirm causation and clinical utility.